J. Overcash

发表

Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET)

S. Simeonov, D. Ionescu, K. Hamed, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis)

A. Barth, E. Dumont, Y. Tao, 2020, Antimicrobial Agents and Chemotherapy.

Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid

Guennaelle Dieppois, F. Wittke, B. Heller, 2020, Antimicrobial Agents and Chemotherapy.

Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia.

T. Wiemken, J. Ramirez, W. Self, 2019, Vaccine.

Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long‐term follow‐up study

T. Hassanein, F. Nevens, M. Burroughs, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis.

T. Hassanein, G. Dore, P. Kwo, 2017, Journal of hepatology.

Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults

J. Ramirez, W. Self, R. Wunderink, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

N. Lewin-Koh, I. Rosas, N. Hanania, 2021, Intensive Care Medicine.

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Karla P. Zepeda, Christina C. Chang, Kamil H A Kim, 2022, Annals of Internal Medicine.

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Christina C. Chang, R. Hyzy, Akram Khan, 2022, The Lancet Respiratory Medicine.

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

E. Nordh, Yi-Chung Lee, R. Sommerville, 2020, Lancet Neurology.

Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection

J. Kort, Sandra S. Lovell, W. O'Riordan, 2015, Antimicrobial Agents and Chemotherapy.

Bone and Joint Tissue Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery

A. Janin, A. Haouala, F. Wittke, 2018, Antimicrobial Agents and Chemotherapy.

Single-dose oritavancin in the treatment of acute bacterial skin infections.

W. O'Riordan, G. Corey, G. Moeck, 2014, The New England journal of medicine.

Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b Study

S. Bai, L. Garrity-Ryan, J. Steenbergen, 2019, Antimicrobial Agents and Chemotherapy.

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1

T. File, A. Torres, M. Wilcox, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and safety of ceftobiprole in patients aged 65 years or older: a post hoc analysis of three Phase III studies.

T. Welte, T. Scheeren, K. Hamed, 2021, Future microbiology.

Quantification of D1B (D5) receptors in dopamine D1A receptor‐deficient mice

R. Mailman, J. Drago, D. Montague, 2001, Synapse.

1688. Omadacycline in Female Adults With Cystitis: Results From a Randomized, Double-Blinded, Adaptive Phase 2 Study

P. Eckburg, A. Serio, E. Tzanis, 2020 .

Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with 1 Cystitis: Results from a Phase 1 Study 2

L. Garrity-Ryan, J. Steenbergen, E. Tzanis, 2019 .

Phase 1 Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis

J. Overcash, J. Zhi, Regina Yavel, 2021, Clinical pharmacology in drug development.

Clinical Results with a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19

G. Criner, J. Janc, Richard A. Miller, 2021, medRxiv.

Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1

J. Lieske, D. Magen, M. Sweetser, 2021, Kidney international reports.

Performance of PCR/Electrospray Ionization-Mass Spectrometry on Whole Blood for Detection of Bloodstream Microorganisms in Patients with Suspected Sepsis

K. Carroll, D. Brealey, A. Limaye, 2020, Journal of Clinical Microbiology.

Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

Karla P. Zepeda, Hansie M Mathelier, J. Felius, 2023, Neurology and Therapy.

Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia.

T. Wiemken, J. Ramirez, W. Self, 2019, Vaccine.

Succession Planning for Vail Fire and Emergency Services: Firefighter Safety through Leadership Development

James Overcash, J. Overcash, 2007 .

Phase I Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects with Actinic Keratosis

D. Cutler, J. Overcash, J. Zhi, 2020 .